Short Term
Mean Reversion
Neutral
Trend
Very Strong
Event
Very Weak
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Very Strong
Momentum
Price
Very Strong
Earnings
Neutral
Growth
Earnings
Very Weak
Dividends
Very Strong
Quality
Capital Efficiency
Weak
Balance Sheet
Strong
Telephone
61.3.9420.8235
Address
Level 1 510 Church Street Cremorne, Victoria (VIC) 3121
Description
Monash IVF Group Ltd. engages in the field of fertility services. It operates through the Australia IVF and Ultrasound, and International IV segments. The Australia IVF and Ultrasound segment provides assisted reproductive services, ultrasound, and other related services. The International IV segment focuses on reproductive services in southeast Asia. The company was founded on April 30, 2014 and is headquartered in Cremorne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.54 - 1.29
Trade Value (12mth)
AU$406,058.00
1 week
-15.85%
1 month
-14.29%
YTD
-45.45%
1 year
-41.53%
All time high
2.38
EPS 3 yr Growth
36.00%
EBITDA Margin
24.50%
Operating Cashflow
$9m
Free Cash Flow Return
2.30%
ROIC
6.40%
Interest Coverage
9.00
Quick Ratio
0.50
Shares on Issue (Fully Dilluted)
390m
HALO Sector
Healthcare
Next Company Report Date
26-Aug-26
Ex Dividend Date (est.)
06-Mar-25
Next Dividend Pay Date (est.)
11-Apr-25
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
22 August 25 |
MVF FY25 Appendix 4E and Financial Report
×
MVF FY25 Appendix 4E and Financial Report |
22 August 25 |
FY25 Results Announcement
×
FY25 Results Announcement |
22 August 25 |
FY25 MVF Results Announcement
×
FY25 MVF Results Announcement |
22 August 25 |
Appendix 4G
×
Appendix 4G |
20 August 25 |
Independent Review into Incidents completed
×
Independent Review into Incidents completed |
16 July 25 |
Appointment of Interim Chief Financial Officer
×
Appointment of Interim Chief Financial Officer |
16 July 25 |
Release of Restricted Shares held in Escrow
×
Release of Restricted Shares held in Escrow |
03 July 25 |
Acting CEO Remuneration Update
×
Acting CEO Remuneration Update |
24 June 25 |
Final Director's Interest Notice
×
Final Director's Interest Notice |
16 June 25 |
Response to ASX Aware Letter
×
Response to ASX Aware Letter |
12 June 25 |
Resignation of CEO & Managing Director
×
Resignation of CEO & Managing Director |
12 June 25 |
Ceasing to be a substantial holder from CGF
×
Ceasing to be a substantial holder from CGF |
12 June 25 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
10 June 25 |
Clinic Incident
×
Clinic Incident |
20 May 25 |
FY25 Profit Guidance Update
×
FY25 Profit Guidance Update |
23 April 25 |
Response to ASX Aware Letter
×
Response to ASX Aware Letter |
16 April 25 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
15 April 25 |
Change in substantial holding from SOL
×
Change in substantial holding from SOL |
10 April 25 |
Media Report following Brisbane clinic incident
×
Media Report following Brisbane clinic incident |
09 April 25 |
Becoming a substantial holder
×
Becoming a substantial holder |
14 March 25 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
27 February 25 |
1H25 Appendix 4D and Financial Report
×
1H25 Appendix 4D and Financial Report |
27 February 25 |
Dividend/Distribution - MVF
×
Dividend/Distribution - MVF |
27 February 25 |
MVF Delivers Revenue and Earnings Growth in 1H25
×
MVF Delivers Revenue and Earnings Growth in 1H25 |
27 February 25 |
1H25 Results Presentation
×
1H25 Results Presentation |
07 February 25 |
Change in substantial holding from SOL
×
Change in substantial holding from SOL |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.